Patients with low glomerular filtration rates and high glycated hemoglobin levels fared worse in this study, highlighting the need for continuous monitoring of systemic health.
Though dyslipidemia is associated with this complication, new research shows that reduced HDL levels and elevated cholesterol and triglycerides may actually have a protective effect.
Nearly $1 billion was spent from 2012 to 2021—practically all by the NIH—and the number of published papers on the topic increased 3.5-fold, but new drug approvals were scant.